Cavalier Investments’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,837
Closed -$85.5K 84
2024
Q3
$85.5K Buy
11,837
+690
+6% +$4.98K 0.03% 84
2024
Q2
$121K Buy
11,147
+310
+3% +$3.37K 0.04% 79
2024
Q1
$203K Buy
10,837
+569
+6% +$10.7K 0.07% 81
2023
Q4
$223K Buy
10,268
+240
+2% +$5.2K 0.08% 90
2023
Q3
$206K Buy
10,028
+349
+4% +$7.18K 0.08% 93
2023
Q2
$455K Buy
+9,679
New +$455K 0.17% 92